AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 157 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.22 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $569,587 | -17.0% | 24,797 | +1.5% | 0.02% | -43.8% |
Q4 2022 | $685,910 | +3.0% | 24,427 | +3.8% | 0.03% | +52.4% |
Q3 2022 | $666,000 | +31.6% | 23,537 | +4.0% | 0.02% | +40.0% |
Q2 2022 | $506,000 | +28.1% | 22,626 | +68.1% | 0.02% | +87.5% |
Q1 2022 | $395,000 | -11.0% | 13,458 | +1.7% | 0.01% | -11.1% |
Q4 2021 | $444,000 | -23.7% | 13,233 | +5.0% | 0.01% | -18.2% |
Q3 2021 | $582,000 | -6.6% | 12,603 | +8.3% | 0.01% | +10.0% |
Q2 2021 | $623,000 | +39.7% | 11,634 | +28.5% | 0.01% | +25.0% |
Q1 2021 | $446,000 | +27.8% | 9,055 | +15.5% | 0.01% | 0.0% |
Q4 2020 | $349,000 | +41.9% | 7,837 | +9.7% | 0.01% | 0.0% |
Q3 2020 | $246,000 | -31.7% | 7,141 | +5.2% | 0.01% | -38.5% |
Q2 2020 | $360,000 | +150.0% | 6,786 | +66.5% | 0.01% | +85.7% |
Q1 2020 | $144,000 | -18.2% | 4,076 | +11.4% | 0.01% | +16.7% |
Q4 2019 | $176,000 | +81.4% | 3,660 | +29.7% | 0.01% | +100.0% |
Q3 2019 | $97,000 | -31.7% | 2,821 | -1.1% | 0.00% | -40.0% |
Q2 2019 | $142,000 | +20.3% | 2,851 | +63.0% | 0.01% | -16.7% |
Q1 2019 | $118,000 | +61.6% | 1,749 | +9.9% | 0.01% | +100.0% |
Q4 2018 | $73,000 | -31.1% | 1,592 | +15.7% | 0.00% | -25.0% |
Q3 2018 | $106,000 | -83.5% | 1,376 | +11.7% | 0.00% | -91.3% |
Q2 2018 | $642,000 | +621.3% | 1,232 | +2.4% | 0.05% | +820.0% |
Q1 2018 | $89,000 | +41.3% | 1,203 | +14.2% | 0.01% | 0.0% |
Q4 2017 | $63,000 | +5.0% | 1,053 | +16.6% | 0.01% | 0.0% |
Q3 2017 | $60,000 | +42.9% | 903 | +10.0% | 0.01% | +25.0% |
Q2 2017 | $42,000 | +27.3% | 821 | +44.8% | 0.00% | -83.3% |
Q1 2016 | $33,000 | – | 567 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |